20-37931671-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_080607.3(VSTM2L):c.158G>A(p.Arg53Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000192 in 1,613,312 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_080607.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VSTM2L | NM_080607.3 | c.158G>A | p.Arg53Gln | missense_variant | 2/4 | ENST00000373461.9 | NP_542174.1 | |
VSTM2L | XM_011528530.2 | c.158G>A | p.Arg53Gln | missense_variant | 2/3 | XP_011526832.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VSTM2L | ENST00000373461.9 | c.158G>A | p.Arg53Gln | missense_variant | 2/4 | 1 | NM_080607.3 | ENSP00000362560 | P1 | |
VSTM2L | ENST00000448944.1 | c.158G>A | p.Arg53Gln | missense_variant | 2/3 | 3 | ENSP00000406537 | |||
VSTM2L | ENST00000373459.4 | c.122-12310G>A | intron_variant | 3 | ENSP00000362558 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152222Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000359 AC: 9AN: 250416Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135396
GnomAD4 exome AF: 0.0000185 AC: 27AN: 1461090Hom.: 0 Cov.: 32 AF XY: 0.0000138 AC XY: 10AN XY: 726882
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152222Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74358
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 14, 2024 | The c.158G>A (p.R53Q) alteration is located in exon 2 (coding exon 2) of the VSTM2L gene. This alteration results from a G to A substitution at nucleotide position 158, causing the arginine (R) at amino acid position 53 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at